Skip to content
Unrated Drug recall · FDA · Published January 13, 2025

Major Pharmaceuticals Duloxetine Capsules Recall: Nitrosamine Impurity Risk

Major Pharmaceuticals recalls 20mg Duloxetine capsules due to potential nitrosamine impurities. This could pose health risks if consumed. Affected lots: N01530 (exp 01/2025) and N01540 (exp 01/2025).

🇺🇸 FDA recall #D-0212-2025DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
✎ GovInfoNow plain-language explainer

What happened, in plain English

Major Pharmaceuticals is recalling 20mg Duloxetine Delayed-Release Capsules that may contain unsafe levels of nitrosamine impurities. This could pose health risks if taken as directed. The recall affects specific lot numbers with expiration dates in January 2025. Read more at govinfonow.com/recall/32333-major-pharmaceuticals-duloxetine-capsules-recall-nitrosamine-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32333-major-pharmaceuticals-duloxetine-capsules-recall-nitrosamine-impurity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0212-2025

Cite this page

“Major Pharmaceuticals Duloxetine Capsules Recall: Nitrosamine Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32333-major-pharmaceuticals-duloxetine-capsules-recall-nitrosamine-impurity-risk. Based on FDA recall #D-0212-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0212-2025%22&limit=1).

Why it’s dangerous

The capsules may contain nitrosamine impurities above FDA safety limits. Nitrosamines are known carcinogens that can increase cancer risk with long-term exposure. However, the exact health risk from this specific impurity level is not clearly stated in the recall.

Who’s affected

People who have the recalled lot numbers (N01530 or N01540) with expiration dates of January 2025. Prescriptions for this medication are typically for those with depression or back pain.

How to tell if you have this one

Check the blister pack for lot number N01530 (expiring 01/2025) or N01540 (expiring 01/2025). The product is a prescription-only 20mg Duloxetine capsule.

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Number

    Look for the lot number on the blister pack: N01530 or N01540 with expiration date January 2025.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Jan 13, 202512. FDA classified it Class II: Jan 29, 202523. Published in FDA’s Enforcement Report: Feb 5, 202534. FDA terminated the recall: Mar 5, 2026420252026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0212-2025 (January 13, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0212-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA